Lv1
18 积分 2022-09-05 加入
Current practices and trends of breast-conserving surgery in China: A nationwide cross-sectional survey
12天前
已完结
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors
1个月前
已完结
Implementation of digital health technology in clinical trials: the 6R framework
1个月前
已完结
TQB2440 compared with reference pertuzumab for HER2-positive, ER/PgR-negative, early or locally advanced breast cancer: a multicenter, randomized, double-blind, parallel-controlled, phase III equivalence trial
5个月前
已完结
Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis
11个月前
已完结
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
11个月前
已关闭
皖公网安备34019202002308
